Mark Godish in Oklahoma City, Oklahoma

Home Oklahoma Oklahoma City

Mark Godish has Pulmonary Disease as his primary medical specialty. Their primary office is: 4300 Mcauley Blvd in Oklahoma City, Oklahoma. There are 3 additional office locations for Mark Godish that can be viewed towards the end of their profile.

They're a part of the: Mercy Clinic Oklahoma Communities medical group which has around 488 members. You can call their office at 405-936-5455 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Indiana University School Of Medicine and graduated in 2004 (around 20 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Mark Godish Office Phone and Directions

Mark Godish
Mercy Clinic Oklahoma Communities
4300 Mcauley Blvd
Oklahoma City, Oklahoma 73120
405-936-5455

Patient Ratings
Please rate your experience with Mark Godish below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 405-936-5455

Enter a starting address:

Healthcare Info for Mark Godish

Medical School: Indiana University School Of Medicine
Graduation Year: 2004
The Primary Medical Specialty for Mark Godish is listed as: Pulmonary Disease
Approximate Years of Experience: 20
PAC (PECOS ID)#: 1850491549
NPI #: 1689632937
NPI Created On: 05/03/2006
NPI Last Updated Listed as: 05/20/2014
Primary Taxonomy Code: 207R00000X
License Number:
1350-TEP
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Emergent insertion of breathing tube into windpipe cartilage using an endoscope
Measurement and graphic recording of total and timed exhaled air capacity
Determination of lung volumes using plethysmography
Measurement of lung diffusing capacity
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Hospital discharge day management, 30 minutes or less
Critical care delivery critically ill or injured patient, first 30-74 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788563985

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: OPSUMIT

Open Associated Drug #1: 66215-501-30

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788563979

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788563981

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788563983

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $5

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801611297

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801612087

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $30

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801614347

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $3

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802105279

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802111528

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802242591

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Additional Office Locations

1. Mercy Clinic Oklahoma Communities
4300 W Memorial Rd
Oklahoma City, OK 73120
Group Members: 488

Phone: 405-936-5455

Enter a starting address:

2. Mercy Clinic Oklahoma Communities
13313 N Meridian Ave C
Oklahoma City, OK 73120
Mercy Clinic
Group Members: 488

Phone: 405-936-5455

Enter a starting address:

3. Mercy Clinic Oklahoma Communities
13313 N Meridian Ave D
Oklahoma City, OK 73120
Mercy Clinic
Group Members: 488

Phone: 405-936-5455

Enter a starting address:

Pulmonary Disease Professionals in Oklahoma City

1.
Stacey Foshee

3100 Sw 89th St
Oklahoma-city, OK

2.
Gregory Mckinnis MD

608 Nw 9th St
Oklahoma-city, OK

3.
Gregory Mckinnis MD

1000 N Lee Ave
Oklahoma-city, OK
Healthfirst Physicians Management Services, Inc.

4.
Gregory Mckinnis MD

3418 Nw 135th St
Oklahoma-city, OK
Nextgen Sleep Llc

5.
Kevin Oneal

5501 N Portland
Oklahoma-city, OK
Integris Ambulatory Care Corporation

6.
Kevin Oneal

3366 Nw Expressway
Oklahoma-city, OK
Integris Ambulatory Care Corporation

Providers in Mercy Clinic Oklahoma Communities

1.John Abbott

4140 W Memorial Rd
Oklahoma City Ok 73120-8365
Mercy Clinic Oklahoma Communities
General Surgery

2.Jean Abed

4205 Mcauley Blvd
Oklahoma City Ok 73120-9309
Mercy Clinic Oklahoma Communities
Gastroenterology

3.David Abernethy

4300 Mcauley Blvd
Oklahoma City Ok 73120-8302
Mercy Clinic Oklahoma Communities
Hospitalist

4.David Abernethy

4300 W Memorial Rd
Oklahoma City Ok 73120-8304
Mercy Clinic Oklahoma Communities
Hospitalist

5.Ghaith Al-qudah

435 N Monte Vista St
Ada Ok 74820-4676
Mercy Clinic Oklahoma Communities
General Surgery

6.Junaid Alam

430 N Monte Vista St
Ada Ok 74820-4610
Mercy Clinic Oklahoma Communities
Internal Medicine

View all 488 members of Mercy Clinic Oklahoma Communities medical group